A detailed history of Sg Americas Securities, LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Sg Americas Securities, LLC holds 4,360 shares of LEGN stock, worth $185,648. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,360
Holding current value
$185,648
% of portfolio
0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$43.55 - $59.88 $189,878 - $261,076
4,360 New
4,360 $212,000
Q1 2024

May 06, 2024

SELL
$55.06 - $69.99 $1.17 Million - $1.48 Million
-21,179 Reduced 52.9%
18,854 $1.06 Million
Q4 2023

Jan 12, 2024

BUY
$57.25 - $69.74 $766,062 - $933,190
13,381 Added 50.21%
40,033 $2.41 Million
Q3 2023

Oct 13, 2023

SELL
$63.16 - $76.5 $8.36 Million - $10.1 Million
-132,424 Reduced 83.25%
26,652 $1.79 Million
Q2 2023

Jul 10, 2023

BUY
$46.28 - $75.01 $113,524 - $183,999
2,453 Added 1.57%
159,076 $11 Million
Q1 2023

Apr 28, 2023

BUY
$43.42 - $57.37 $596,243 - $787,804
13,732 Added 9.61%
156,623 $7.55 Million
Q4 2022

Feb 02, 2023

BUY
$38.8 - $55.46 $204,320 - $292,052
5,266 Added 3.83%
142,891 $7.13 Million
Q3 2022

Oct 31, 2022

SELL
$38.15 - $57.1 $117,921 - $176,496
-3,091 Reduced 2.2%
137,625 $5.62 Million
Q2 2022

Jul 29, 2022

SELL
$33.54 - $55.0 $452,756 - $742,445
-13,499 Reduced 8.75%
140,716 $7.74 Million
Q1 2022

Apr 29, 2022

SELL
$31.02 - $48.18 $4.28 Million - $6.65 Million
-138,010 Reduced 47.23%
154,215 $5.6 Million
Q4 2021

Feb 07, 2022

BUY
$41.14 - $56.98 $12 Million - $16.7 Million
292,225 New
292,225 $13.6 Million

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $7.13B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.